Inflammatory response to coronary artery bypass surgery: Does the heme-oxygenase-1 gene microsatellite polymorphism play a role?

被引:0
|
作者
Jules Sanders
Emma Hawe
David Brull
Hugh Montgomery
Steve Humphries
机构
[1] Centre for Cardiovascular Genetics
[2] British Heart Foundation Laboratories
[3] Department of Medicine
[4] Royal Free & University College London Medical School
[5] Rayne Building
[6] 5 University Street
[7] London WC1E 6JF
[8] UK
关键词
heme oxygenase · polymorphism · inflammation · bypass surgery;
D O I
暂无
中图分类号
R654.2 [心脏];
学科分类号
1002 ; 100210 ;
摘要
Background Heme-oxygenase 1 (HO-1) is a rate-limiting enzyme in the degradation of heme to bilirubin, ferritin and carbon monoxide (CO) and may have significant anti-inflammatory function. The HO-1 gene promoter region shows microsatellite polymorphism with different (GT)n repeats, reported to differently induce gene expression, with the short allele associated with higher gene expression. We measured the acute inflammatory response using coronary artery bypass surgery (CABG) as a well-characterized and uniform stimulus and examined the correlation between levels of IL-6, C-reactive protein (CRP) and fibrinogen and their relationship to HO-1 genotype.Methods Two hundred and seventy-five consecutive patients undergoing CABG were genotyped for the HO-1 promoter polymorphism using PCR and automated DNA capillary sequencer. IL-6, CRP and fibrinogen were measured at baseline and 6, 24, 48, 72, 96 and 120 hours after CABG.Results Complete IL-6,CRP and fibrinogen measures were available in 220 patients. Before surgery IL-6 levels showed a strong correlation with CRP and fibrinogen ( r =0.48, P <0.0001; r =0.41, P <0.0001 respectively), with a significant correlation between CRP and fibrinogen ( r =0.61, P <0.0001). All three acute phase reactants showed a significant increase after CABG. After surgery, peak IL-6 was strongly correlated with peak CRP ( r =0.34, P =0.0009) but not with peak fibrinogen ( r =0.15, P =0.13), while peak CRP and peak fibrinogen were significantly correlated ( r =0.415, P <0.0001). HO-1 allelic repeats ranged from 22-42, with (GT) 25 and (GT) 32 being the two most common alleles, and subsequently divided into three groups according to previous published work: <30(GT)n were designated as S (short), 30-37(GT)n as M (middle) and long repeats with >37(GT)n as L (long); allele frequency 0.35, 0.58 and 0.07 respectively. Baseline CRP differed by genotype: those carrying at least one long allele having higher CRP than those with no long allele (3.76±0.79 vs. 2.07±0.17, P =0.013). Conversely, those carrying at least one short allele had higher fibrinogen levels than those with no short allele (3.83±0.79 vs. 3.51±0.88, P =0.006). Conclusions There is a strong correlation between the measured acute phase reactants both at baseline and after the inflammatory response to CABG in patients with coronary disease. There was an association between the HO-1 microsatellite polymorphism and CRP and fibrinogen levels at baseline but there was no similar association following CABG. This may indicate that HO-1 is associated with chronic atherosclerotic inflammatory processes rather than acute.
引用
收藏
页码:1285 / 1290
页数:6
相关论文
共 50 条
  • [21] Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter and the Risk of Atrial Fibrillation in Taiwanese
    Hsu, Lung-An
    Yeh, Yung-Hsin
    Kuo, Chi-Tai
    Chen, Ying-Hwa
    Chang, Gwo-Jyh
    Tsai, Feng-Chun
    Chen, Wei-Jan
    PLOS ONE, 2014, 9 (09):
  • [22] Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells?
    Trigona, Wendy L.
    Porter, Cynthia M.
    Horvath-Arcidiacono, Judith A.
    Majumdar, Anish S.
    Bloom, Eda T.
    ANTIOXIDANTS & REDOX SIGNALING, 2007, 9 (06) : 751 - 756
  • [23] Heme oxygenase-1 gene promotor polymorphism and restenosis after coronary stenting
    Tiroch, K.
    Koch, W.
    von Beckerath, N.
    Schomig, A.
    Kastrati, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 154 - 154
  • [24] Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting
    Tiroch, Klaus
    Koch, Werner
    von Beckerath, Nikolas
    Kastrati, Adnan
    Schoemig, Albert
    EUROPEAN HEART JOURNAL, 2007, 28 (08) : 968 - 973
  • [25] Survival of Overweight Patients After Coronary Artery Bypass Surgery. Does the "Obesity Paradox" Play a Role?
    Efros, L. A.
    Samorodskaya, I. V.
    KARDIOLOGIYA, 2015, 55 (07) : 45 - 50
  • [26] Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter Is Not Associated With Alcoholic Liver Disease Severity
    Lemaire, Anne
    Trepo, Eric
    Ouziel, Romy
    Gustot, Thierry
    Moreno, Christophe
    Degre, Delphine
    Minsart, Charlotte
    Quertinmont, Eric
    Vercruysse, Vincent
    De Wilde, Virginie
    le Moine, Olivier
    Deviere, Jacques
    Abramowicz, Marc
    le Moine, Alain
    Lemmers, Arnaud
    HEPATOLOGY, 2014, 59 (01) : 352 - 353
  • [27] Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar
    Takeda, M
    Kikuchi, M
    Ubalee, R
    Na-Bangchang, K
    Ruangweerayut, R
    Shibahara, S
    Imai, S
    Hirayama, K
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2005, 58 (05) : 268 - 271
  • [28] The 5′ flanking polymorphism in the heme oxygenase-1 gene is associated with coronary artery disease susceptibility in Japanese patients with hypercholesterolemia
    Kaneda, H
    Taguchi, J
    Aizawa, T
    Ohno, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 307S - 307S
  • [29] Female Gender and Differences in Outcome after Isolated Coronary Artery Bypass Graft Surgery: Does Age Play a Role?
    Arif, Rawa
    Farag, Mina
    Gertner, Victor
    Szabo, Gabor
    Weymann, Alexander
    Veres, Gabor
    Ruhparwar, Arjang
    Bekeredjian, Raffi
    Bruckner, Tom
    Karck, Matthias
    Kallenbach, Klaus
    Beller, Carsten J.
    PLOS ONE, 2016, 11 (02):
  • [30] Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease
    Pechlaner, R.
    Willeit, P.
    Summerer, M.
    Santer, P.
    Egger, G.
    Kronenberg, F.
    Demetz, E.
    Weiss, G.
    Tsimikas, S.
    Witztum, J.
    Willeit, K.
    Iglseder, B.
    Paulweber, B.
    Kedenko, L.
    Haun, M.
    Gieger, C.
    Mueller-Nurasyid, M.
    Peters, A.
    Willeit, J.
    Kiechl, S.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 250 - 250